Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Sinovac’s Healive® Vaccine Not Responsible for Infant’s Death

publication date: Dec 31, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech (北京科兴生物制品有限公司) reported that Healive®, the company’s hepatitis A vaccine, has been cleared of any responsibility in the death of a two-year-old infant, who had been given the vaccine just two days before his death. According to discoveries made during an autopsy, the cause of death was myocarditis, an inflammation of the muscular part of the heart, which is usually caused by infection. Healive was not a factor in this problem. More details...

Stock Symbol: (NYSE Alternext US: SVA)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners